Lung cancer
Pro Research Analysisby 
Searched over 200M research papers for "lung cancer"
Lung Cancer Epidemiology and Risk Factors
Lung cancer is the most frequently diagnosed cancer and the leading cause of cancer-related deaths worldwide, with an estimated 2 million new cases and 1.8 million deaths annually 1610. Tobacco smoking is the primary risk factor, accounting for 80–90% of all lung cancer cases, but other factors such as radon exposure, occupational hazards (like asbestos), air pollution, and family history also contribute significantly to risk 469. The incidence of lung cancer is rising globally, particularly in developing countries due to increased tobacco use and industrialization . Notably, adenocarcinoma has become the most common histologic subtype, surpassing squamous cell carcinoma, and its incidence is increasing, especially among never-smokers and Asian women 2910.
Types and Molecular Characteristics of Lung Cancer
Lung cancer is broadly divided into non-small cell lung cancer (NSCLC, about 85% of cases) and small cell lung cancer (SCLC, about 15%) . NSCLC includes subtypes such as adenocarcinoma and squamous cell carcinoma, with specific DNA mutations (e.g., EGFR, KRAS) allowing for further molecular classification. EGFR mutations are more common in Asian patients, while KRAS mutations are more frequent in Caucasians 510. These molecular differences influence both the biology of the disease and treatment responses.
Advances in Screening and Early Detection
Early detection of lung cancer is crucial for improving survival rates. Screening with low-dose computed tomography (CT) has been shown to help identify lung cancer at earlier, more treatable stages 57. However, most patients (about 75%) are still diagnosed at advanced stages (III/IV), where survival rates are much lower . Computer-aided diagnosis (CAD) systems and advanced imaging techniques are being developed to assist radiologists in detecting and classifying lung nodules more accurately, potentially improving early diagnosis .
Treatment Progress: Surgery, Chemotherapy, and Targeted Therapies
For early-stage NSCLC, surgical resection offers the best chance for cure, with 5-year survival rates up to 70% for small, localized tumors 25. In locally advanced cases, combined chemotherapy and radiation therapy have improved outcomes, and newer chemotherapy regimens offer better results for metastatic disease . SCLC is highly responsive to chemotherapy, and advances in radiation therapy have improved long-term survival prospects .
Recent years have seen remarkable progress in targeted therapies and immune checkpoint inhibitors, which have transformed outcomes for many patients with advanced lung cancer . The use of predictive biomarkers has enabled more personalized treatment approaches, further improving survival and quality of life .
Psychological Impact and Quality of Life
Lung cancer patients often experience a high symptom burden and significant psychological distress, including anxiety and depression, which are worsened by stigma and the side effects of treatment . Early assessment of symptoms and psychological distress, along with integration of palliative care, can improve quality of life for both patients and their families .
Conclusion
Lung cancer remains a major global health challenge due to its high incidence, late-stage diagnosis, and significant mortality. While tobacco smoking is the leading risk factor, other environmental and genetic factors also play important roles. Advances in screening, molecular classification, and treatment—especially targeted therapies and immunotherapy—have improved outcomes for many patients. Continued efforts in early detection, risk reduction, and supportive care are essential to further reduce the burden of lung cancer worldwide 1245+5 MORE.
Sources and full results
Most relevant research papers on this topic
Cancer Progress and Priorities: Lung Cancer
Lung cancer is a complex disease with multiple risk factors, and early detection and treatment are crucial for reducing cancer-related deaths.
DOI